It has recently been reported that the ratio of non-responders to clopidogrel, a P2Y12 antagonist, in the subjects with DM or impaired glucose tolerance is greater than the subjects without them in the cohort consisting of patients with minor ischemic stroke or transient ischemic attack [29]. This evidence concerns the gene P2RY12 and ischemic stroke.